Neonatal hyperbilirubinemia management: a model for change

Area of Science:

• Neonatal Health
• Public Health Surveillance
• Pediatric Medicine

Background:

• Active public health surveillance for hyperbilirubinemia and kernicterus is currently lacking.
• The Hospital Corporation of America (HCA) implemented universal hyperbilirubinemia screening for newborns.
• Screening was implemented before hospital discharge for all infants within the HCA system.

Purpose of the Study:

• To establish a model for active monitoring of hyperbilirubinemia occurrence.
• To track the incidence of severe hyperbilirubinemia (total serum bilirubin [TSB] ≥30 mg/dL).
• To improve healthcare quality for newborns and collect vital public health data.

Main Methods:

• Implementation of universal hyperbilirubinemia screening in over 98% of HCA hospitals within the first year.
• Monitoring of infants born within the HCA system for TSB levels.
• Data collection on infants identified with TSB ≥30 mg/dL between May and December 2004, and in 2006.

Main Results:

• From May to December 2004, 13 infants had TSB ≥30 mg/dL.
• By 2006, the number of infants with TSB ≥30 mg/dL born in HCA hospitals decreased to seven.
• The screening program demonstrated a reduction in severe hyperbilirubinemia cases.

Conclusions:

• The HCA's universal newborn screening program serves as an effective model for hyperbilirubinemia surveillance.
• Active monitoring can lead to improved healthcare quality and reduced incidence of severe jaundice.
• This approach facilitates the collection of crucial public health information on neonatal hyperbilirubinemia.